Fulcrum Therapeutics, Inc. · NASDAQ:FULC

Tang Capital Management LLC reported a 8.20% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)

Event Jun 3, 2026 · Filed Jun 10, 2026

Tang Capital Management LLC reported a 8.20% stake in Fulcrum Therapeutics, Inc., 5,451,800 shares, as a passive investor on Jun 3, 2026. Filed Jun 10, 2026 (Schedule 13G).

Stake
8.20%
Shares
5,451,800
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
TANG CAPITAL MANAGEMENT, LLC8.20%5,451,800
KEVIN TANG8.20%5,451,800
TANG CAPITAL PARTNERS, LP1.90%1,249,373
TANG CAPITAL PARTNERS INTERNATIONAL, LP2.50%1,703,690
TANG CAPITAL PARTNERS III, INC1.90%1,249,367
TANG CAPITAL PARTNERS IV, INC1.90%1,249,370

Source

View original at SEC

Related